Sampre Nutrition

Which are the latest news on Sampre Nutrition?

Why is Sampre Nutritions Ltd falling/rising?

As of 05-Sep, Sampre Nutritions Ltd's stock price is rising to 6.63, up 4.91%, driven by a 22.32% gain over the past week and strong short-term momentum despite significant year-to-date declines. The stock's performance is bolstered by outpacing the Sensex and its sector, although declining investor participation raises some concerns.

As of 05-Sep, Sampre Nutritions Ltd's stock price is rising, currently at 6.63, reflecting an increase of 0.31 or 4.91%. This upward movement can be attributed to several factors. Over the past week, the stock has shown a remarkable gain of 22.32%, significantly outperforming the Sensex, which has declined by 0.97% during the same period. Additionally, the stock has been on a consecutive gain streak for the last five days, indicating strong positive momentum.<BR><BR>Despite a year-to-date decline of 73.35% and a one-year drop of 68.80%, the recent performance suggests a recovery phase, particularly in the short term. The stock is currently trading higher than its 5-day, 20-day, and 50-day moving averages, which typically signals positive sentiment among investors. However, it is worth noting that the stock is still below its 100-day and 200-day moving averages, indicating that while there is short-term strength, longer-term trends may still be under pressure.<BR><BR>Moreover, the stock has outperformed its sector by 5.09% today, further contributing to its rising price. However, there is a slight concern regarding falling investor participation, as the delivery volume has decreased by 4.67% compared to the 5-day average. Despite this, the stock remains liquid enough for trading, which supports its current upward trajectory. Overall, the combination of recent gains, positive short-term performance, and relative outperformance against benchmarks are key reasons for the rise in Sampre Nutritions Ltd's stock price.

Who are in the management team of Sampre Nutrition?

The management team of Sampre Nutrition includes B K Gurbani (Managing Director), Vishal Ratan Gurbani (Vice President & Whole-Time Director), and several Independent Directors: Banala Jayaprakash Reddy, Umra Singh Sirohi, and Vimal Suresh, along with Deepak Bissa as Company Secretary & Compliance Officer.

The management team of Sampre Nutrition includes the following individuals:<BR><BR>1. **B K Gurbani** - Managing Director<BR>2. **Banala Jayaprakash Reddy** - Independent Director<BR>3. **Umra Singh Sirohi** - Independent Director<BR>4. **Vishal Ratan Gurbani** - Vice President & Whole-Time Director<BR>5. **Vimal Suresh** - Independent Director<BR>6. **Deepak Bissa** - Company Secretary & Compliance Officer<BR><BR>If you need more specific information about any of these individuals or their roles, feel free to ask!

What does Sampre Nutrition do?

Sampre Nutritions Ltd is a micro-cap FMCG company that manufactures sugar candies, including products for Cadbury India Ltd. As of June 2026, it reported net sales of ₹15 Cr and a net profit of ₹1 Cr, with a market cap of ₹52 Cr.

Overview: <BR>Sampre Nutritions Ltd is a micro-cap company in the FMCG industry, specializing in the manufacturing of sugar candies.<BR><BR>History: <BR>Incorporated in 1991, Sampre Nutritions Ltd was promoted by The Gurbani Group. The company has been manufacturing candy products for Cadbury India Ltd since August 1996 and entered into an agreement to manufacture "DAIRY MILK ECLAIRS" in 2000. The latest quarterly results reported net sales and profit for June 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 15 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 1 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 52 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 15.00 <BR>Industry P/E: 44 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.17 <BR>Return on Equity: 3.33% <BR>Price to Book: 0.48 <BR><BR>Contact Details: <BR>Address: P No 133 Indl Estate, Medchal Telangana: 501401 <BR>Tel: 91-08418-222427/28 <BR>Email: gurbani@gurbanigroup.in <BR>Website: http://www.sampreltd.com

Who are the peers of the Sampre Nutrition?

Sampre Nutrition's peers include Oceanic Foods, Artemis ADR Mark, Ceeta Industries, Warren Tea, Saboo Sodium, Diana Tea Co, Anjani Foods, Italian Edibles, and ATC Energies. Sampre Nutrition has the lowest 1-year return at -72.13% among its peers, which generally exhibit varying levels of management risk and growth ratings.

Peers: The peers of Sampre Nutrition are Oceanic Foods, Artemis ADR Mark, Ceeta Industries, Warren Tea, Saboo Sodium, Diana Tea Co, Anjani Foods, Italian Edibles, and ATC Energies.<BR><BR>Quality Snapshot: Excellent management risk is observed at ATC Energies, while Average management risk is found at Oceanic Foods and Italian Edibles. Below Average management risk is noted for Artemis ADR Mark, Ceeta Industries, Warren Tea, Sampre Nutrition, Saboo Sodium, Diana Tea Co, Anjani Foods, and the rest. Growth is rated as Good for Artemis ADR Mark, Average for Oceanic Foods, Ceeta Industries, Italian Edibles, and Below Average for Sampre Nutrition, Warren Tea, Saboo Sodium, Diana Tea Co, Anjani Foods, and the rest. Capital Structure is rated as Good for Artemis ADR Mark, Average for Oceanic Foods, and Below Average for Sampre Nutrition, Ceeta Industries, Warren Tea, Saboo Sodium, Diana Tea Co, Anjani Foods, Italian Edibles, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Diana Tea Co at -1.95%, while the peer with the lowest is Sampre Nutrition at -72.13%, indicating that Sampre Nutrition's return is significantly worse than that of its peers. Additionally, peers with negative six-month returns include Sampre Nutrition, Ceeta Industries, Warren Tea, Saboo Sodium, Anjani Foods, and the rest.

How big is Sampre Nutrition?

As of 31st August, Sampre Nutritions Ltd has a market capitalization of 52.00 Cr, with recent net sales of 47.34 Cr and a net profit of 3.57 Cr. The company reported shareholder's funds of 107.36 Cr and total assets of 133.83 Cr as of March 2026.

As of 31st August, Sampre Nutritions Ltd has a market capitalization of 52.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Sampre Nutritions Ltd reported Net Sales of 47.34 Cr and a Net Profit of 3.57 Cr.<BR><BR>For the reporting period of March 2026, the company had Shareholder's Funds amounting to 107.36 Cr and Total Assets of 133.83 Cr.

Should I buy, sell or hold Sampre Nutritions Ltd?

Are Sampre Nutritions Ltd latest results good or bad?

Sampre Nutritions Ltd's latest results show strong revenue growth and a return to profitability, but concerns about declining operating margins and reliance on tax credits raise doubts about sustainability. Investors should proceed with caution and monitor future performance closely.

Sampre Nutritions Ltd's latest results present a mixed picture. On one hand, the company reported a significant increase in revenue and net profit for Q4 FY26, with net sales rising by 104.33% quarter-on-quarter to ₹15.10 crores and a net profit of ₹1.35 crores, marking a 117.74% increase from the previous quarter. This revenue growth is impressive and indicates a strong volume expansion in their core business.<BR><BR>However, there are serious concerns regarding the sustainability of this performance. The operating margin has plummeted to just 2.85%, down from 20.16% in the previous quarter, which raises questions about the company's operational efficiency. Additionally, the net profit was heavily influenced by a substantial tax credit, suggesting that the underlying profitability may not be as strong as it appears.<BR><BR>The company has also faced significant challenges over the past year, including a 47.39% decline in stock price year-to-date and a bearish technical trend. Furthermore, the average return on equity (ROE) is only 2.77%, which is below industry standards, indicating poor capital efficiency.<BR><BR>In summary, while the latest results show positive growth in revenue and a return to profitability, the sharp decline in operating margins and reliance on one-time tax benefits cast doubt on whether this performance can be sustained. Investors should be cautious and closely monitor upcoming quarters to see if the company can maintain this momentum.

When is the next results date for Sampre Nutritions Ltd?

The next results date for Sampre Nutritions Ltd is 13 February 2026.

The next results date for Sampre Nutritions Ltd is scheduled for 13 February 2026.

How has been the historical performance of Sampre Nutrition?

Sampre Nutrition experienced a significant decline in financial health from March 2024 to March 2025, with net sales slightly decreasing and total expenditure rising sharply, resulting in a negative operating profit and a loss after tax of -7.67 Cr. Despite an increase in total assets, the company's financial outlook is concerning due to negative profit margins and escalating costs.

Answer:<BR>The historical performance of Sampre Nutrition shows a significant decline in financial health from March 2024 to March 2025.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Sampre Nutrition reported net sales of 25.12 Cr, a slight decrease from 25.15 Cr in the previous year. Total operating income mirrored this trend, remaining nearly unchanged at 25.12 Cr compared to 25.15 Cr in March 2024. However, total expenditure saw a substantial increase to 28.99 Cr from 21.02 Cr, primarily driven by a rise in employee costs from 7.75 Cr to 10.81 Cr and other expenses escalating from 3.74 Cr to 9.82 Cr. This led to an operating profit (PBDIT) of -3.50 Cr, a stark contrast to the positive 4.25 Cr reported in the prior year. Consequently, profit before tax plummeted to -7.52 Cr from 0.49 Cr, resulting in a profit after tax of -7.67 Cr compared to a modest profit of 0.23 Cr in March 2024. The earnings per share also reflected this downturn, falling to -3.65 from 0.32. On the balance sheet, total liabilities surged to 115.43 Cr from 44.75 Cr, while total assets increased to the same figure, indicating a significant rise in the company's financial obligations. The book value per share improved to 42.44 from 26.75, but the overall financial outlook for Sampre Nutrition appears concerning, with negative profit margins and increasing costs overshadowing any positive asset growth.

Who are the top shareholders of the Sampre Nutrition?

The top shareholder of Sampre Nutrition is Wave Capital Ltd, holding 12.52% of the shares. Individual shareholders own 31.28%, with Brahma Gurbani as the largest promoter at 4.94%, and there are no pledged promoter holdings or investments from mutual funds or foreign institutional investors.

The top shareholders of Sampre Nutrition include Wave Capital Ltd, which holds the largest public share at 12.52%. Among individual shareholders, they collectively own 31.28% of the company. The promoter with the highest holding is Brahma Gurbani, who owns 4.94%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors holding shares.

Is Sampre Nutrition overvalued or undervalued?

As of June 5, 2025, Sampre Nutrition is considered overvalued with a risky valuation grade, reflected by a PE ratio of -7.39, an EV to EBITDA ratio of -19.19, and a troubling ROE of -35.54%, significantly underperforming its peers and the market with a year-to-date return of -60.75%.

As of 5 June 2025, Sampre Nutrition's valuation grade has moved from expensive to risky, indicating a significant shift in its perceived value. The company is currently assessed as overvalued. Key ratios highlight its precarious position: the PE ratio stands at -7.39, the EV to EBITDA ratio is at -19.19, and the ROE is a concerning -35.54%. <BR><BR>In comparison to its peers, Sampre Nutrition's metrics are starkly unfavorable; for instance, Hindustan Unilever has a PE ratio of 53.88, while Nestlé India boasts a PE of 75.2. This stark contrast underscores the challenges Sampre faces in the FMCG sector. Additionally, the company's stock performance has been disappointing, with a year-to-date return of -60.75%, significantly underperforming the Sensex's 5.62% return.

What is the technical trend for Sampre Nutrition?

As of June 4, 2025, Sampre Nutrition's technical trend has shifted to a moderate bearish stance, supported by bearish signals from Bollinger Bands, moving averages, and monthly MACD, despite some mildly bullish indicators on the weekly timeframe.

As of 4 June 2025, the technical trend for Sampre Nutrition has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this include the weekly MACD showing mildly bullish but the monthly MACD is bearish, indicating a divergence in trends. The Bollinger Bands are bearish on both weekly and monthly time frames, reinforcing the bearish outlook. Daily moving averages are also bearish. The KST shows a mildly bullish signal on the weekly but is bearish on the monthly, while the Dow Theory indicates a mildly bearish stance on the weekly with no trend on the monthly. Overall, the combination of these indicators suggests a bearish sentiment in the current market environment.

Has Sampre Nutrition declared dividend?

No Dividend History Available